The synthesis and the preliminary biological evaluation of the first high affinity radioligand antagonist for the human A3 adenosine receptor, named [3H]-MRE 3008-F20 are reported. [3H]-MRE 3008-20 bound human A3 receptors expressed in CHO cells with K(D) and Bmax value of 0.82 +/- 0.08 nM and 297 +
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptors
β Scribed by Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Delia Preti; Andrea Bovero; Francesca Fruttarolo; Romeo Romagnoli; Allan R. Moorman; Stefania Gessi; Stefania Merighi; Katia Varani; Pier Andrea Borea
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 264 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A series of novel and known 5-substituted 7-amino-2-(2-furyl) [1,2,4]triazolo [1,5a][1,3,5]triazine derivatives were synthesized and tested for adenosine receptor antagonism in radioligand binding assays at all four adenosine receptor subtypes and for inhibition of the agonist-induced cyclic AMP res
## Abstract The synthesis of [^3^H]βCPβ93,129, a potent radioligand for the serotonin 5βHT~1B~ receptor, is described. 5βButoxypyrrolo[3,2βb]pyridine (2) is converted in 3 steps to 5βbutoxyβ1βphenylsulfonylβ2βtritiopyrrolo[3,2βb]pyridine (3c) via lithiation of C2, iodination of that anion, and trit